Study to Reduce Ventilator-Associated Pneumonia in Newborns Using Evidence-Based Practices and Team Training in Neonatal Intensive Care Units
Led by Biobizkaia Health Research Institute · Updated on 2025-11-20
1500
Participants Needed
39
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers aim to develop clear, universal definitions and standardized practices to diagnose and prevent ventilator-associated pneumonia VAP in newborns in neonatal intensive care units NICUs. This project involves creating evidence-based recommendations and best practice protocols for healthcare teams to improve and unify care and diagnosis across participating units. The study is observational and seeks to understand how these interventions reduce the frequency and impact of VAP in neonates undergoing invasive mechanical ventilation.
The study involves several phases initially, researchers provide access to data collection forms and instructions to follow usual diagnostic criteria. Next, all NICU teams receive training on the evidence-based preventive measures and diagnostic criteria. Finally, these trained practices are incorporated into daily care routines. A surveillance registry collects data such as patient demographics, antibiotic use, clinical signs, and diagnostic tests related to VAP throughout invasive ventilation and a short monitoring period after extubation.
Participants are newborns admitted to NICUs who require mechanical ventilation for at least 48 hours. Data collected includes clinical evaluations, radiological and microbiological tests, and antibiotic treatments. Researchers monitor how well preventive measures are implemented and track changes in VAP diagnosis and prevention. The main outcome measured is the impact of this multimodal intervention on VAP incidence from the start of ventilation until extubation plus two extra days in some cases. The study runs through multiple phases including training, data collection, and analysis over several years.
CONDITIONS
Brief Title
Reduction of the Incidence of NAV in Neonatal Units (INBERNAV-Neo)
Research Team
P
Patricia Sanchez Hernandez
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients admitted to participating NICUs who are on invasive mechanical ventilation (IMV) for at least 48 hours
You will not qualify if you...
Patients who require invasive mechanical ventilation for less than 48 hours
Healthcare professional may exclude a patient at any time based on treatment considerations
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - During mechanical ventilation period
Participants undergo diagnostic testing using a blind-protected catheter technique to accurately and safely diagnose ventilator-associated pneumonia (VAP).
Visits occur as needed during invasive mechanical ventilation
Monitoring
Duration - From initiation of invasive mechanical ventilation until extubation plus an additional 2 days of monitoring in some cases
Participants are observed while receiving routine care in neonatal units, including the implementation of a multimodal intervention to reduce the incidence of VAP by training healthcare teams in evidence-based clinical practices.
Continuous monitoring during hospitalization
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Predicting Respiratory Distress Syndrome and Need for Extended Breathing Support in Newborns Born at 32 Weeks or Later in a Lower-Level NICU
Study to Reduce Ventilator-Associated Pneumonia in Newborns Using Evidence-Based Practices and Team Training in Neonatal Intensive Care Units
Study of Ventilator-Associated Pneumonia Diagnosis Accuracy Using SRLF 2017 Criteria in Mechanically Ventilated ICU Adults from 2022 to 2024
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Effect of enhanced ultraviolet germicidal irradiation in the heating ventilation and air conditioning system on ventilator-associated pneumonia in a neonatal intensive care unit.